Picture of LifeStance Health logo

LFST — LifeStance Health News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Lifestance Health Group Inc expected to post a loss of 9 cents a share - Earnings Preview

* Lifestance Health Group Inc  LFST.OQ   LFST.O  is expected
to show a rise in quarterly revenue when it reports  results on
May 9 for the period ending March 31 2024
    * The Scottsdale Arizona-based  company is expected to
report a
18.4% increase in revenue to $298.991 million from $252.59
million a year ago, according to the mean estimate from 5
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Lifestance Health Group
Inc is
for a loss of 9 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 4
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Lifestance
Health
Group Inc is $9.00​, above​ its last closing price of $6.91. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  -0.11       -0.09      -0.12     Missed  -29.2
 Sep. 30 2023  -0.08       -0.08      -0.17     Missed  -112.5
 Jun. 30 2023  -0.09       -0.09      -0.13     Missed  -50​
 Mar. 31 2023  -0.11       -0.11      -0.09     Beat    15.1
 ​​Jan.        -0.13       -0.13      -0.13     Met     -1.3
 1 0001                                                 
 Sep. 30 2022  -0.13       -0.14      -0.11     Beat    20.5​
 Jan. 1 0001   -0.15       -0.14      -0.19     Missed  -35.7
 Mar. 31 2022  -0.20       -0.17      -0.18     Missed  -4.7
 This summary was machine generated May 7 at 16:12 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on LifeStance Health

See all news